Documentation Pharmaceutical Companies Seminar 
PharmTech
JULY 24, 2025
Waite further emphasizes the need for pharmaceutical companies to quickly build internal capabilities in customs compliance, including tariff classification, country of origin documentation, and accurate customs valuation.
pharmaphorum
OCTOBER 20, 2020
The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.
Expert insights. Personalized for you.
52 
Let's personalize your content